[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349058-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-349058-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","shared-patterns-of-dysregulated-gene-expression-across-squamous-cell-carcinomas-unveil-predictors-for-prognosis-and-drug-sensitivity","Shared patterns of dysregulated gene expression across squamous cell carcinomas unveil predictors for prognosis and drug sensitivity","","Shared transcriptional regulatory mechanisms across squamous cell carcinomas (SCCs) remain unclear despite extensive multi-omics work. This study systematically characterizes common and distinct transcriptomic alterations by integrating large-scale gene expression data from SCC tumors and adjacent normal tissues, deriving dysregulated gene expression patterns and quantifying their cross-organ similarity. Gene co-expression network analysis identifies SCC-associated modules and hub genes, refined by subtype analysis and prognostic modeling. Head and neck, esophagus, and cervix SCCs show highly similar dysregulated networks, whereas lung and skin differ. Key epithelial-mesenchymal transition, extracellular matrix remodeling, and immune-related processes correlate with prognosis, and a six-gene signature predicts outcomes and therapy response.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/shared-patterns-of-dysregulated-gene-expression-across-squamous-cell-carcinomas-unveil-predictors-for-prognosis-and-drug-sensitivity/349058/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/shared-patterns-of-dysregulated-gene-expression-across-squamous-cell-carcinomas-unveil-predictors-for-prognosis-and-drug-sensitivity/349058.png","ImageObject",300,407,{"name":42,"@type":43},"Sarah ","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"How were dysregulated gene expression patterns (DGEPs) identified across SCCs?","Question",{"text":63,"@type":64},"The study integrated large-scale gene expression data from SCC tumors and adjacent normal tissues, then derived dysregulated gene expression patterns for tumor versus normal comparisons. Similarity across SCC types was quantified using correlation and regression analyses.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What did the gene co-expression network analysis contribute?",{"text":68,"@type":64},"It identified SCC-associated co-expression modules and hub genes. The biological and clinical significance of these features was further examined using subtype analysis and prognostic modeling.",{"name":70,"@type":61,"acceptedAnswer":71},"Which SCC organs showed the most similar DGEPs and regulatory networks?",{"text":72,"@type":64},"SCCs from the head and neck, esophagus, and cervix shared highly similar DGEPs and regulatory networks. In contrast, lung and skin SCCs displayed more distinct molecular characteristics.",{"name":74,"@type":61,"acceptedAnswer":75},"What prognostic signature was proposed and what did it predict?",{"text":76,"@type":64},"A six-gene prognostic signature (COL1A1, MMP1, SERPINE1, KRT6A, IGF2BP3, SPP1) demonstrated robust predictive power for clinical outcomes and therapy response.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},349058,1790301197,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,124,127,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":120,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":122,"slug":123},9,"Religion & Spirituality",20,"religion-spirituality",{"id":122,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":122,"slug":126},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":131,"language":143,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":12,"update_tm":147,"read_time":148,"preview_page_count":33,"preview_urls":149},962085320529,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nShared patterns of dysregulated gene expression across squamous cell carcinomas unveil predictors for prognosis and drug sensitivity  \nDanke Wang1, Xu Li1, Jiaqi Zhou1, Huangbo Yuan1, Peipei Gao1, Yucan Li1, Yixin Zeng1, Chen Suo2,3,4􀀍 & Xingdong Chen1,2,5,6􀀍  \nDespite extensive multi-omics studies on squamous cell carcinomas (SCCs) across different organs, the shared transcriptional regulatory mechanisms that driving SCC remain unclear. This study systematically identified common and distinct transcriptomic alterations in SCCs, highlighting key genes and pathways with prognostic and therapeutic relevance. By integrating large-scale gene expression data from SCC tumors and adjacent normal tissues, we revealed dysregulated gene expression patterns (DGEPs) and quantified their similarity across SCCs through correlation and regression analyses. Gene co-expression network analysis identified SCC-associated modules and hub genes, whose biological and clinical significance was further explored through subtype analysis and prognostic modeling. Our findings show that SCCs from the head and neck, esophagus, and cervix share highly similar DGEPs and regulatory networks, whereas lung and skin SCCs exhibit more distinct molecular characteristics. Key processes such as epithelial-mesenchymal transition, extracellular matrix remodeling, and immune-related pathways were strongly linked to SCC prognosis. Moreover, a six-gene prognostic signature (COL1A1, MMP1, SERPINE1, KRT6A, IGF2BP3, and SPP1) demonstrated robust predictive power for clinical outcomes and therapy response. These findings provide insights into SCC progression and potential therapeutic targets.  \nKeywords Squamous cell carcinomas, Transcriptome, Epithelial-mesenchymal transition, Immunosuppression, Survival, Drug  \nSquamous cell carcinoma (SCC) is one of the most common types of cancer, primarily occurring in the skin, oral cavity, nasopharynx, esophagus, lung, and cervix. Epidemiological studies have shown that squamous cell carcinomas (SCCs) arising from multiple organ sites account for approximately one-fifth of all cancer deaths, with the total number exceeding two million1–3. SCCs share some of common environmental risk factors, such as smoking, alcohol consumption, and HPV infection4–8. Despite originating from different organs, SCCs share a same pathological mechanism of malignant transformation of squamous epithelial cells, which results in similar histological characteristics across these cancers8. With the advancement of sequencing technologies, accumulating evidence has highlighted significant molecular similarities among SCCs, including DNA mutations, DNA methylation, RNA expression, and alternative splicing events, and these molecular features are notably distinct when compared to other types of solid tumors8–14.  \nSeveral studies have conducted integrative analyses of SCCs from DNA mutation, immune-related gene expression to proteomics15–17. Campbell et al.15 identified shared DNA mutations and methylation features in SCCs by integrating multi-omics data. The associated genes primarily regulate squamous cell stemness, progression, differentiation, and genome integrity. Based on the expression of immune-related genes, Li et al.16 identified six reproducible immune subtypes of cross-organ SCCs and demonstrated that these immune  \n1State Key Laboratory of Genetic Engineering, Human Phenome Institute, Zhangjiang Fudan International Innovation Center, School of Life Science, Fudan University, Shanghai 20032, China. 2Fudan University Taizhou Institute of Health Sciences, Taizhou 225300, Jiangsu, China. 3Department of Epidemiology, School of Public Health, Fudan University, Shanghai 20032, China. 4Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 20032, China. 5National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Sh","cbCaieNK8Dl7qqd4","https://ap.wps.com/l/cbCaieNK8Dl7qqd4","pdf",10830078,"English","# Methods and data integration\n## Dysregulated gene expression patterns across tumors and adjacent normal tissues\n## Similarity quantification via correlation and regression\n# Network and subgroup analyses\n## Gene co-expression network modules and hub genes\n## Subtype analysis and prognostic modeling\n# Cross-organ comparisons and key pathways\n## Shared vs distinct dysregulated regulatory networks\n## Prognosis-linked biological processes\n# Prognostic signature for outcomes and therapy response\n## Six-gene signature and predictive performance","[{\"question\":\"How were dysregulated gene expression patterns (DGEPs) identified across SCCs?\",\"answer\":\"The study integrated large-scale gene expression data from SCC tumors and adjacent normal tissues, then derived dysregulated gene expression patterns for tumor versus normal comparisons. Similarity across SCC types was quantified using correlation and regression analyses.\"},{\"question\":\"What did the gene co-expression network analysis contribute?\",\"answer\":\"It identified SCC-associated co-expression modules and hub genes. The biological and clinical significance of these features was further examined using subtype analysis and prognostic modeling.\"},{\"question\":\"Which SCC organs showed the most similar DGEPs and regulatory networks?\",\"answer\":\"SCCs from the head and neck, esophagus, and cervix shared highly similar DGEPs and regulatory networks. In contrast, lung and skin SCCs displayed more distinct molecular characteristics.\"},{\"question\":\"What prognostic signature was proposed and what did it predict?\",\"answer\":\"A six-gene prognostic signature (COL1A1, MMP1, SERPINE1, KRT6A, IGF2BP3, SPP1) demonstrated robust predictive power for clinical outcomes and therapy response.\"}]","Shared patterns of dysregulated gene expression across squamous cell carcinomas unveil predictors for prognosis and drug sensitivity | PDF",1790081452,48,[150,154,158,162],{"page_no":22,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fe13c0ea8e32bb852196105728e7987f.webp",983,1291,{"page_no":26,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b8666d7ca2206a73d59af2a739d5157d.webp",982,1290,{"page_no":30,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e17007f02fea0ec5bcca467244c81164.webp",981,1289,{"page_no":33,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/989c052c4d31e38e633b71c281c351c5.webp",980,1287]